You just read:

BlueMountain Capital Management and IsZo Capital To Update Shareholders Regarding Lawsuit Against Taro Pharmaceutical Industries, Call for the Resignation of External Directors

News provided by

BlueMountain Capital Management, LLC

Jan 31, 2014, 07:04 EST